ROIVANT SCIENCES LTD. (ROIV) FY2026 Q1 P&L / Income Statement

ROIVANT SCIENCES LTD. (ROIV) FY2026 Q1 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. Consolidated revenue, costs and expenses.

Revenue

1,442,000 US dollars

Operating costs, net of other operating income (calculated)

367,435,000 US dollars

Loss from operations

negative 365,993,000 US dollars

Other income (expense), net (calculated)

71,429,000 US dollars

Loss before income taxes

negative 294,564,000 US dollars

Income tax (benefit) expense

negative 3,958,000 US dollars

Net loss

negative 290,606,000 US dollars

Undisclosed sources

1,442,000 US dollars. The filing reports revenue as one line and discloses no sources of it.

Total operating expenses

367,827,000 US dollars

Gain on litigation settlement

negative 392,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to ROIVANT SCIENCES LTD.: −$189.84 M; to noncontrolling interests: −$100.77 M.